Philip Gribbon

Philip is assistant Head of Department at Fraunhofer IME ScreeningPort in Hamburg, Germany. He has worked in Academic, biotechnology and Pharma industry for 20 years, most recently in the area of target validation and small molecule screening. His research interests cover the development of biophysical technologies directed towards improving the process of drug discovery. Philip has a PhD from Imperial College, London.